Moura RP - Search Results

1

The biotechnological potential of proteases from hematophagous arthropod vectors.

de Araújo CN, Santiago PB, Causin Vieira G, Silva GDS, Moura RP, Bastos IMD, de Santana JM. de Araújo CN, et al. Among authors: moura rp. Front Cell Infect Microbiol. 2023 Oct 26;13:1287492. doi: 10.3389/fcimb.2023.1287492. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37965257 Free PMC article. No abstract available.

2

Functionalized retinoic acid lipid nanocapsules promotes a two-front attack on inflammation and lack of demyelination on neurodegenerative disorders.

Moura RP, Carvalho ED, Martins C, des Rieux A, Pêgo AP, Sarmento B. Moura RP, et al. J Control Release. 2023 Jun;358:43-58. doi: 10.1016/j.jconrel.2023.04.034. Epub 2023 Apr 28. J Control Release. 2023. PMID: 37088306 Free article.

3

Multifunctional nanomedicine strategies to manage brain diseases.

Faria P, Pacheco C, Moura RP, Sarmento B, Martins C. Faria P, et al. Among authors: moura rp. Drug Deliv Transl Res. 2023 May;13(5):1322-1342. doi: 10.1007/s13346-022-01256-w. Epub 2022 Nov 7. Drug Deliv Transl Res. 2023. PMID: 36344871 Review.

4

Advances on erythrocyte-mimicking nanovehicles to overcome barriers in biological microenvironments.

Castro F, Martins C, Silveira MJ, Moura RP, Pereira CL, Sarmento B. Castro F, et al. Among authors: moura rp. Adv Drug Deliv Rev. 2021 Mar;170:312-339. doi: 10.1016/j.addr.2020.09.001. Epub 2020 Sep 15. Adv Drug Deliv Rev. 2021. PMID: 32946921 Review.

5

[Bibliometric analysis of the scientific evidence on violence perpetrated against the elderly].

Moura LKB, Azevedo UN, Wingerter DG, Ferreira MAF, Maciel MPR, Moura RP, Silva AMD, Alves MDSCF. Moura LKB, et al. Among authors: moura rp. Cien Saude Colet. 2020 Jun;25(6):2143-2152. doi: 10.1590/1413-81232020256.226322018. Epub 2018 Sep 14. Cien Saude Colet. 2020. PMID: 32520261 Free article. Portuguese.

6

Lipid nanocapsules to enhance drug bioavailability to the central nervous system.

Moura RP, Pacheco C, Pêgo AP, des Rieux A, Sarmento B. Moura RP, et al. J Control Release. 2020 Jun 10;322:390-400. doi: 10.1016/j.jconrel.2020.03.042. Epub 2020 Apr 2. J Control Release. 2020. PMID: 32247807 Review.

7

NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients.

Jandrey EHF, Moura RP, Andrade LNS, Machado CL, Campesato LF, Leite KRM, Inoue LT, Asprino PF, da Silva APM, de Barros ACSD, Carvalho A, de Lima VC, Carraro DM, Brentani HP, da Cunha IW, Soares FA, Parmigiani RB, Chammas R, Camargo AA, Costa ÉT. Jandrey EHF, et al. Among authors: moura rp. NPJ Breast Cancer. 2019 Apr 5;5:11. doi: 10.1038/s41523-019-0106-x. eCollection 2019. NPJ Breast Cancer. 2019. PMID: 30963110 Free PMC article.

8

Blood-brain barrier receptors and transporters: an insight on their function and how to exploit them through nanotechnology.

Moura RP, Martins C, Pinto S, Sousa F, Sarmento B. Moura RP, et al. Expert Opin Drug Deliv. 2019 Mar;16(3):271-285. doi: 10.1080/17425247.2019.1583205. Epub 2019 Feb 26. Expert Opin Drug Deliv. 2019. PMID: 30767695 Review.

9

Therapeutic Monoclonal Antibodies Delivery for the Glioblastoma Treatment.

Sousa F, Moura RP, Moreira E, Martins C, Sarmento B. Sousa F, et al. Among authors: moura rp. Adv Protein Chem Struct Biol. 2018;112:61-80. doi: 10.1016/bs.apcsb.2018.03.001. Epub 2018 Mar 30. Adv Protein Chem Struct Biol. 2018. PMID: 29680243 Review.

10

The role of non-endothelial cells on the penetration of nanoparticles through the blood brain barrier.

Moura RP, Almeida A, Sarmento B. Moura RP, et al. Prog Neurobiol. 2017 Dec;159:39-49. doi: 10.1016/j.pneurobio.2017.09.001. Epub 2017 Sep 9. Prog Neurobiol. 2017. PMID: 28899762 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page